Thinning of a layer of nerve cells in the retina, the light-sensitive tissue at the back of the eye, was associated with slower information processing in people with multiple sclerosis (MS), independent of physical disability, a study found. Researchers concluded that the findings support retinal imaging as a potential…
Discussion
I have been known to occasionally use an experience from my time in U.S. Army special operations forces to illustrate or make a point in this column. Since I “write” with voice-to-text, I can honestly say that I had trouble writing that with a straight face. The right word to…
Discussion
In people newly diagnosed with relapsing-remitting multiple sclerosis (MS), a higher number of oligoclonal bands (OCBs) — bands of antibodies found in the fluid surrounding the brain and spinal cord — may reflect more widespread lesions on MRI scans and poorer verbal learning and memory, a study found. “While…
Discussion
Briumvi (ublituximab-xiiy) may be more effective than Kesimpta (ofatumumab) or Ocrevus (ocrelizumab) at preventing disability progression among people with relapsing forms of multiple sclerosis (MS), according to an indirect comparison of clinical trial data. “In the absence of head-to-head clinical trials, [matching-adjusted indirect comparison] provides a valuable statistical…
Discussion
Anti-CD20 therapies, a type of treatment approved for multiple sclerosis (MS), may be highly effective in MS partly because they reduce the immune system’s ongoing response to the Epstein-Barr virus (EBV), a well-established risk factor for MS. That’s according to a study involving nearly 200 people that found…
Get regular updates to your inbox.
